Element Materials Technology acquired Avomeen, a pharmaceutical analytical testing company, significantly expanding the group’s life sciences business unit in North America.
Avomeen focuses on pharmaceutical testing, biotechnology and FDA-regulated consumer products with a team of 80 scientists and experts. Avomeen enhances Element’s experience in a wide range of scientific disciplines, reinforcing its offering in the main areas of strategic growth, including formulation chemistry, product manufacturing, extractables and leachables and large molecule testing.
Avomeen operates a facility in Ann Arbor, MI. The company is registered by the FDA, licensed by the DEA and accredited by ISO, all providing a comprehensive extension to Element’s existing range of services and supporting its strategy of becoming a full service solution provider in the life sciences market. Avomeen achieved record revenue growth of 23% in 2020. Avomeen has actively supported companies that develop virus diagnostics and therapies, as well as manufacturers of products such as hand sanitizer.
Jo Wetz, Element’s CEO, said: “This is our third acquisition in 2021 and helps build Element’s growing position in the life sciences sector, expanding our presence in the American pharmaceutical market. Avomeen’s service offerings and recent entry into new end markets complement Element’s current pharmaceutical services and customers, and the team’s deep technical knowledge and additional capacity provide us with a significant increase in scale in the USA. ”
Mark Harvill, CEO of Avomeen, said: “We are excited to join the global Element family and combine our complementary capabilities to offer an even wider range of services and value to our customers. Element’s focus on scientific excellence and quality, together with its partnership with customers and employees, aligns well with Avomeen’s values and what we will continue to do collectively as a company. “
Element’s existing network of life sciences laboratories provides specialized testing services, including chemical and physical characterization; formulation development; storage stability studies, extractable and leachable; virology and virus identification; cell bank; antimicrobial and microbial tests; elemental impurity testing on a wide range of drugs, nutraceuticals, medical devices and consumer products; cytotoxicity, biocharge, endotoxin and TOC tests; identification of pathogens; bacterial and nutritional chemistry analysis.